Wolverine 2.0 30MG (BPC-157 / TB-500 Blend / KPV)
Spend $1200 get a free Precision Kit
PEPTIDE CLASS
Regenerative Peptide Blend • Tissue Repair & Immunomodulatory Research Peptides
OVERVIEW
The BPC-157 / TB-500 / KPV Blend combines three extensively researched peptides with complementary biological properties. This investigational blend has attracted interest for its potential to support studies involving tissue repair, cellular regeneration, inflammatory signaling, and recovery following experimental injury.
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protective gastric protein and is commonly investigated for its potential role in supporting angiogenesis, tissue regeneration, and musculoskeletal healing.
TB-500, a synthetic fragment of the naturally occurring protein thymosin beta-4, is widely researched for its ability to influence cell migration, cytoskeletal organization, angiogenesis, and tissue remodeling. It has become a valuable compound in studies of connective tissue repair and recovery.
KPV (Lys-Pro-Val) is a naturally occurring tripeptide derived from alpha-melanocyte-stimulating hormone (α-MSH). It is primarily researched for its ability to modulate inflammatory pathways and support immune homeostasis through mechanisms distinct from corticosteroids.
Together, these peptides provide researchers with a comprehensive platform for investigating tissue regeneration, wound healing, inflammatory regulation, and recovery processes across multiple biological systems.
POTENTIAL RESEARCH BENEFITS
Current research is exploring this blend for its potential to:
Investigate soft tissue regeneration
Support tendon and ligament repair research
Study muscle recovery and tissue remodeling
Explore angiogenesis and vascular regeneration
Examine collagen production and extracellular matrix remodeling
Investigate modulation of inflammatory pathways
Support gastrointestinal tissue repair research
Explore recovery following experimental musculoskeletal injury
Study immune homeostasis and cellular repair mechanisms
MECHANISM OF ACTION
Each peptide within this blend contributes through complementary biological pathways.
BPC-157 has been investigated for its ability to support angiogenic signaling, fibroblast activity, collagen organization, and cellular migration involved in tissue repair.
TB-500 influences actin dynamics and promotes cell migration, proliferation, and angiogenesis, making it an important research compound for connective tissue remodeling and regenerative processes.
KPV interacts with inflammatory signaling pathways by helping regulate pro-inflammatory cytokine activity while supporting balanced immune responses. This mechanism has made it a valuable peptide for studying inflammation-related tissue recovery.
The combined activity of these three peptides allows researchers to investigate the interplay between regeneration, inflammation, vascular development, and extracellular matrix remodeling within a single experimental model.
PRODUCT SPECIFICATIONS
Compound Name: BPC-157 / TB-500 / KPV Blend
Peptide Components:
BPC-157 (Pentadecapeptide)
TB-500 (Thymosin Beta-4 Fragment)
KPV (Lys-Pro-Val)
Research Category: Regenerative & Immunomodulatory Peptide Blend
Appearance: White to off-white lyophilized powder
What is the BPC-157 / TB-500 / KPV Blend?
This blend combines three complementary research peptides that are frequently studied for their roles in tissue regeneration, inflammatory modulation, and recovery. By targeting multiple biological pathways simultaneously, the combination enables researchers to investigate complex healing and repair mechanisms across musculoskeletal, connective tissue, gastrointestinal, and immune-related models.
What is this blend commonly researched for?
Researchers commonly investigate this peptide blend in studies involving:
Soft tissue repair
Tendon and ligament regeneration
Muscle recovery
Wound healing
Angiogenesis
Collagen synthesis
Gastrointestinal tissue integrity
Inflammatory signaling
Immune regulation
Connective tissue remodeling
Recovery following experimental injury